BioSig Technologies, Inc. (BSGM)
- Previous Close
1.6300 - Open
1.6500 - Bid 1.4800 x 1000
- Ask 1.5800 x 900
- Day's Range
1.3800 - 1.6893 - 52 Week Range
0.2620 - 16.5000 - Volume
415,718 - Avg. Volume
1,197,375 - Market Cap (intraday)
17.245M - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
-- - EPS (TTM)
-4.7000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
55.00
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
www.biosig.comRecent News: BSGM
Performance Overview: BSGM
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BSGM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BSGM
Valuation Measures
Market Cap
17.08M
Enterprise Value
17.34M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
622.86
Price/Book (mrq)
--
Enterprise Value/Revenue
963.40
Enterprise Value/EBITDA
-0.62
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-449.00%
Return on Equity (ttm)
-5,977.35%
Revenue (ttm)
141k
Net Income Avi to Common (ttm)
-30.04M
Diluted EPS (ttm)
-4.7000
Balance Sheet and Cash Flow
Total Cash (mrq)
389k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-6.62M
Research Analysis: BSGM
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell